Global Migraine Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Migraine Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Migraine Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Migraine Drugs by Country/Region, 2017, 2022 & 2028

2.2 Migraine Drugs Segment by Type

2.2.1 Sumatriptan

2.2.2 Zolmitriptan

2.2.3 Rizatriptan

2.2.4 Others Drug

2.3 Migraine Drugs Sales by Type

2.3.1 Global Migraine Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Migraine Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Migraine Drugs Sale Price by Type (2017-2022)

2.4 Migraine Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Household Use

2.4.4 Others

2.5 Migraine Drugs Sales by Application

2.5.1 Global Migraine Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Migraine Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Migraine Drugs Sale Price by Application (2017-2022)

3 Global Migraine Drugs by Company

3.1 Global Migraine Drugs Breakdown Data by Company

3.1.1 Global Migraine Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Migraine Drugs Sales Market Share by Company (2020-2022)

3.2 Global Migraine Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Migraine Drugs Revenue by Company (2020-2022)

3.2.2 Global Migraine Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Migraine Drugs Sale Price by Company

3.4 Key Manufacturers Migraine Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Migraine Drugs Product Location Distribution

3.4.2 Players Migraine Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Migraine Drugs by Geographic Region

4.1 World Historic Migraine Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Migraine Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Migraine Drugs Annual Revenue by Geographic Region

4.2 World Historic Migraine Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Migraine Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Migraine Drugs Annual Revenue by Country/Region

4.3 Americas Migraine Drugs Sales Growth

4.4 APAC Migraine Drugs Sales Growth

4.5 Europe Migraine Drugs Sales Growth

4.6 Middle East & Africa Migraine Drugs Sales Growth

5 Americas

5.1 Americas Migraine Drugs Sales by Country

5.1.1 Americas Migraine Drugs Sales by Country (2017-2022)

5.1.2 Americas Migraine Drugs Revenue by Country (2017-2022)

5.2 Americas Migraine Drugs Sales by Type

5.3 Americas Migraine Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Migraine Drugs Sales by Region

6.1.1 APAC Migraine Drugs Sales by Region (2017-2022)

6.1.2 APAC Migraine Drugs Revenue by Region (2017-2022)

6.2 APAC Migraine Drugs Sales by Type

6.3 APAC Migraine Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Migraine Drugs by Country

7.1.1 Europe Migraine Drugs Sales by Country (2017-2022)

7.1.2 Europe Migraine Drugs Revenue by Country (2017-2022)

7.2 Europe Migraine Drugs Sales by Type

7.3 Europe Migraine Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Migraine Drugs by Country

8.1.1 Middle East & Africa Migraine Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Migraine Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Migraine Drugs Sales by Type

8.3 Middle East & Africa Migraine Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Migraine Drugs

10.3 Manufacturing Process Analysis of Migraine Drugs

10.4 Industry Chain Structure of Migraine Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Migraine Drugs Distributors

11.3 Migraine Drugs Customer

12 World Forecast Review for Migraine Drugs by Geographic Region

12.1 Global Migraine Drugs Market Size Forecast by Region

12.1.1 Global Migraine Drugs Forecast by Region (2023-2028)

12.1.2 Global Migraine Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Migraine Drugs Forecast by Type

12.7 Global Migraine Drugs Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Migraine Drugs Product Offered

13.1.3 Allergan Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Migraine Drugs Product Offered

13.2.3 Merck Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Migraine Drugs Product Offered

13.3.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Teva

13.4.1 Teva Company Information

13.4.2 Teva Migraine Drugs Product Offered

13.4.3 Teva Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teva Main Business Overview

13.4.5 Teva Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Migraine Drugs Product Offered

13.5.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Johnson & Johnson

13.6.1 Johnson & Johnson Company Information

13.6.2 Johnson & Johnson Migraine Drugs Product Offered

13.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Johnson & Johnson Main Business Overview

13.6.5 Johnson & Johnson Latest Developments

13.7 Endo International

13.7.1 Endo International Company Information

13.7.2 Endo International Migraine Drugs Product Offered

13.7.3 Endo International Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Endo International Main Business Overview

13.7.5 Endo International Latest Developments

13.8 GlaxoSmithKline

13.8.1 GlaxoSmithKline Company Information

13.8.2 GlaxoSmithKline Migraine Drugs Product Offered

13.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 GlaxoSmithKline Main Business Overview

13.8.5 GlaxoSmithKline Latest Developments

13.9 Impax

13.9.1 Impax Company Information

13.9.2 Impax Migraine Drugs Product Offered

13.9.3 Impax Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Impax Main Business Overview

13.9.5 Impax Latest Developments

13.10 Abbott

13.10.1 Abbott Company Information

13.10.2 Abbott Migraine Drugs Product Offered

13.10.3 Abbott Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Abbott Main Business Overview

13.10.5 Abbott Latest Developments

13.11 Bayer

13.11.1 Bayer Company Information

13.11.2 Bayer Migraine Drugs Product Offered

13.11.3 Bayer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Bayer Main Business Overview

13.11.5 Bayer Latest Developments

13.12 Eli Lilly

13.12.1 Eli Lilly Company Information

13.12.2 Eli Lilly Migraine Drugs Product Offered

13.12.3 Eli Lilly Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Eli Lilly Main Business Overview

13.12.5 Eli Lilly Latest Developments

13.13 Ethypharm

13.13.1 Ethypharm Company Information

13.13.2 Ethypharm Migraine Drugs Product Offered

13.13.3 Ethypharm Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Ethypharm Main Business Overview

13.13.5 Ethypharm Latest Developments

13.14 Kowa Pharmaceuticals America

13.14.1 Kowa Pharmaceuticals America Company Information

13.14.2 Kowa Pharmaceuticals America Migraine Drugs Product Offered

13.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Kowa Pharmaceuticals America Main Business Overview

13.14.5 Kowa Pharmaceuticals America Latest Developments

13.15 Winston Pharmaceuticals

13.15.1 Winston Pharmaceuticals Company Information

13.15.2 Winston Pharmaceuticals Migraine Drugs Product Offered

13.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Winston Pharmaceuticals Main Business Overview

13.15.5 Winston Pharmaceuticals Latest Developments

13.16 AstraZeneca

13.16.1 AstraZeneca Company Information

13.16.2 AstraZeneca Migraine Drugs Product Offered

13.16.3 AstraZeneca Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 AstraZeneca Main Business Overview

13.16.5 AstraZeneca Latest Developments

14 Research Findings and Conclusion

Table 1. Migraine Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Migraine Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Sumatriptan

Table 4. Major Players of Zolmitriptan

Table 5. Major Players of Rizatriptan

Table 6. Major Players of Others Drug

Table 7. Global Migraine Drugs Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Migraine Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Migraine Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Migraine Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Migraine Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Migraine Drugs Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Migraine Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Migraine Drugs Revenue by Application (2017-2022)

Table 15. Global Migraine Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Migraine Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Migraine Drugs Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Migraine Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Migraine Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Migraine Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Migraine Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Migraine Drugs Producing Area Distribution and Sales Area

Table 23. Players Migraine Drugs Products Offered

Table 24. Migraine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Migraine Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Migraine Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Migraine Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Migraine Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Migraine Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Migraine Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Migraine Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Migraine Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Migraine Drugs Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Migraine Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Migraine Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Migraine Drugs Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Migraine Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Migraine Drugs Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Migraine Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Migraine Drugs Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Migraine Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Migraine Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Migraine Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Migraine Drugs Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Migraine Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Migraine Drugs Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Migraine Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Migraine Drugs Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Migraine Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Migraine Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Migraine Drugs Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Migraine Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Migraine Drugs Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Migraine Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Migraine Drugs Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Migraine Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Migraine Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Migraine Drugs Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Migraine Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Migraine Drugs Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Migraine Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Migraine Drugs

Table 68. Key Market Challenges & Risks of Migraine Drugs

Table 69. Key Industry Trends of Migraine Drugs

Table 70. Migraine Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Migraine Drugs Distributors List

Table 73. Migraine Drugs Customer List

Table 74. Global Migraine Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Migraine Drugs Sales Market Forecast by Region

Table 76. Global Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Migraine Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Migraine Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Migraine Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Migraine Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Migraine Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Migraine Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Migraine Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Migraine Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Migraine Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Migraine Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Migraine Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Migraine Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Migraine Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Allergan Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Allergan Migraine Drugs Product Offered

Table 96. Allergan Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Allergan Main Business

Table 98. Allergan Latest Developments

Table 99. Merck Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Merck Migraine Drugs Product Offered

Table 101. Merck Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Merck Main Business

Table 103. Merck Latest Developments

Table 104. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Pfizer Migraine Drugs Product Offered

Table 106. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Pfizer Main Business

Table 108. Pfizer Latest Developments

Table 109. Teva Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Teva Migraine Drugs Product Offered

Table 111. Teva Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Teva Main Business

Table 113. Teva Latest Developments

Table 114. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Pfizer Migraine Drugs Product Offered

Table 116. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Pfizer Main Business

Table 118. Pfizer Latest Developments

Table 119. Johnson & Johnson Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Johnson & Johnson Migraine Drugs Product Offered

Table 121. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Johnson & Johnson Main Business

Table 123. Johnson & Johnson Latest Developments

Table 124. Endo International Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Endo International Migraine Drugs Product Offered

Table 126. Endo International Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Endo International Main Business

Table 128. Endo International Latest Developments

Table 129. GlaxoSmithKline Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. GlaxoSmithKline Migraine Drugs Product Offered

Table 131. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. GlaxoSmithKline Main Business

Table 133. GlaxoSmithKline Latest Developments

Table 134. Impax Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Impax Migraine Drugs Product Offered

Table 136. Impax Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Impax Main Business

Table 138. Impax Latest Developments

Table 139. Abbott Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Abbott Migraine Drugs Product Offered

Table 141. Abbott Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Abbott Main Business

Table 143. Abbott Latest Developments

Table 144. Bayer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Bayer Migraine Drugs Product Offered

Table 146. Bayer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Bayer Main Business

Table 148. Bayer Latest Developments

Table 149. Eli Lilly Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Eli Lilly Migraine Drugs Product Offered

Table 151. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Eli Lilly Main Business

Table 153. Eli Lilly Latest Developments

Table 154. Ethypharm Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Ethypharm Migraine Drugs Product Offered

Table 156. Ethypharm Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 157. Ethypharm Main Business

Table 158. Ethypharm Latest Developments

Table 159. Kowa Pharmaceuticals America Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Kowa Pharmaceuticals America Migraine Drugs Product Offered

Table 161. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 162. Kowa Pharmaceuticals America Main Business

Table 163. Kowa Pharmaceuticals America Latest Developments

Table 164. Winston Pharmaceuticals Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Winston Pharmaceuticals Migraine Drugs Product Offered

Table 166. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 167. Winston Pharmaceuticals Main Business

Table 168. Winston Pharmaceuticals Latest Developments

Table 169. AstraZeneca Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. AstraZeneca Migraine Drugs Product Offered

Table 171. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 172. AstraZeneca Main Business

Table 173. AstraZeneca Latest Developments

List of Figures

Figure 1. Picture of Migraine Drugs

Figure 2. Migraine Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Migraine Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Migraine Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Migraine Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Sumatriptan

Figure 10. Product Picture of Zolmitriptan

Figure 11. Product Picture of Rizatriptan

Figure 12. Product Picture of Others Drug

Figure 13. Global Migraine Drugs Sales Market Share by Type in 2021

Figure 14. Global Migraine Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Migraine Drugs Consumed in Hospitals

Figure 16. Global Migraine Drugs Market: Hospitals (2017-2022) & (K Pcs)

Figure 17. Migraine Drugs Consumed in Clinics

Figure 18. Global Migraine Drugs Market: Clinics (2017-2022) & (K Pcs)

Figure 19. Migraine Drugs Consumed in Household Use

Figure 20. Global Migraine Drugs Market: Household Use (2017-2022) & (K Pcs)

Figure 21. Migraine Drugs Consumed in Others

Figure 22. Global Migraine Drugs Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Migraine Drugs Sales Market Share by Application (2017-2022)

Figure 24. Global Migraine Drugs Revenue Market Share by Application in 2021

Figure 25. Migraine Drugs Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Migraine Drugs Revenue Market Share by Company in 2021

Figure 27. Global Migraine Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Migraine Drugs Revenue Market Share by Geographic Region in 2021

Figure 29. Global Migraine Drugs Sales Market Share by Region (2017-2022)

Figure 30. Global Migraine Drugs Revenue Market Share by Country/Region in 2021

Figure 31. Americas Migraine Drugs Sales 2017-2022 (K Pcs)

Figure 32. Americas Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 33. APAC Migraine Drugs Sales 2017-2022 (K Pcs)

Figure 34. APAC Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Europe Migraine Drugs Sales 2017-2022 (K Pcs)

Figure 36. Europe Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Migraine Drugs Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 39. Americas Migraine Drugs Sales Market Share by Country in 2021

Figure 40. Americas Migraine Drugs Revenue Market Share by Country in 2021

Figure 41. United States Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Migraine Drugs Sales Market Share by Region in 2021

Figure 46. APAC Migraine Drugs Revenue Market Share by Regions in 2021

Figure 47. China Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Migraine Drugs Sales Market Share by Country in 2021

Figure 54. Europe Migraine Drugs Revenue Market Share by Country in 2021

Figure 55. Germany Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Migraine Drugs Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Migraine Drugs Revenue Market Share by Country in 2021

Figure 62. Egypt Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Migraine Drugs in 2021

Figure 68. Manufacturing Process Analysis of Migraine Drugs

Figure 69. Industry Chain Structure of Migraine Drugs

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles